220 related articles for article (PubMed ID: 25762405)
1. Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.
Bernardini G; Laschi M; Geminiani M; Braconi D; Vannuccini E; Lupetti P; Manetti F; Millucci L; Santucci A
J Inherit Metab Dis; 2015 Sep; 38(5):807-14. PubMed ID: 25762405
[TBL] [Abstract][Full Text] [Related]
2. Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria.
Laschi M; Tinti L; Braconi D; Millucci L; Ghezzi L; Amato L; Selvi E; Spreafico A; Bernardini G; Santucci A
J Cell Physiol; 2012 Sep; 227(9):3254-7. PubMed ID: 22105303
[TBL] [Abstract][Full Text] [Related]
3. Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria.
Hughes JH; Liu K; Plagge A; Wilson PJM; Sutherland H; Norman BP; Hughes AT; Keenan CM; Milan AM; Sakai T; Ranganath LR; Gallagher JA; Bou-Gharios G
Hum Mol Genet; 2019 Dec; 28(23):3928-3939. PubMed ID: 31600782
[TBL] [Abstract][Full Text] [Related]
4. Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
Galderisi S; Milella MS; Rossi M; Cicaloni V; Rossi R; Giustarini D; Spiga O; Tinti L; Salvini L; Tinti C; Braconi D; Millucci L; Lupetti P; Prischi F; Bernardini G; Santucci A
Arch Biochem Biophys; 2022 Mar; 717():109137. PubMed ID: 35090868
[TBL] [Abstract][Full Text] [Related]
5. Alkaptonuria presenting with ochronotic spondyloarthropathy.
Al-Mahfoudh R; Clark S; Buxton N
Br J Neurosurg; 2008 Dec; 22(6):805-7. PubMed ID: 19085367
[TBL] [Abstract][Full Text] [Related]
6. Structure-Function Relationship of Homogentisate 1,2-dioxygenase: Understanding the Genotype-Phenotype Correlations in the Rare Genetic Disease Alkaptonuria.
Bernini A; Spiga O; Santucci A
Curr Protein Pept Sci; 2023; 24(5):380-392. PubMed ID: 36880186
[TBL] [Abstract][Full Text] [Related]
7. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A
Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606
[TBL] [Abstract][Full Text] [Related]
8. Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins.
Braconi D; Millucci L; Bernini A; Spiga O; Lupetti P; Marzocchi B; Niccolai N; Bernardini G; Santucci A
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):135-146. PubMed ID: 27865997
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.
Tinti L; Spreafico A; Braconi D; Millucci L; Bernardini G; Chellini F; Cavallo G; Selvi E; Galeazzi M; Marcolongo R; Gallagher JA; Santucci A
J Cell Physiol; 2010 Oct; 225(1):84-91. PubMed ID: 20648626
[TBL] [Abstract][Full Text] [Related]
10. Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review.
Ranganath LR; Norman BP; Gallagher JA
J Inherit Metab Dis; 2019 Sep; 42(5):776-792. PubMed ID: 31282009
[TBL] [Abstract][Full Text] [Related]
11. Alkaptonuria: a very rare metabolic disorder.
Aquaron R
Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
[TBL] [Abstract][Full Text] [Related]
12. Alkaptonuria is a novel human secondary amyloidogenic disease.
Millucci L; Spreafico A; Tinti L; Braconi D; Ghezzi L; Paccagnini E; Bernardini G; Amato L; Laschi M; Selvi E; Galeazzi M; Mannoni A; Benucci M; Lupetti P; Chellini F; Orlandini M; Santucci A
Biochim Biophys Acta; 2012 Nov; 1822(11):1682-91. PubMed ID: 22850426
[TBL] [Abstract][Full Text] [Related]
13. Ashy ears.
Rallis E; Kintzoglou S
ScientificWorldJournal; 2010 Aug; 10():1530-1. PubMed ID: 20694448
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and mechanisms of ochronosis in alkaptonuria.
Braconi D; Millucci L; Bernardini G; Santucci A
Free Radic Biol Med; 2015 Nov; 88(Pt A):70-80. PubMed ID: 25733348
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of alkaptonuria patients: single center experience.
Bozaci AE; Yazici H; Canda E; Uçar SK; Guvenc MS; Berdeli A; Habif S; Coker M
J Pediatr Endocrinol Metab; 2022 Jul; 35(7):913-923. PubMed ID: 35671204
[TBL] [Abstract][Full Text] [Related]
16. Histological and Ultrastructural Characterization of Alkaptonuric Tissues.
Millucci L; Bernardini G; Spreafico A; Orlandini M; Braconi D; Laschi M; Geminiani M; Lupetti P; Giorgetti G; Viti C; Frediani B; Marzocchi B; Santucci A
Calcif Tissue Int; 2017 Jul; 101(1):50-64. PubMed ID: 28271171
[TBL] [Abstract][Full Text] [Related]
17. Alkaptonuria in Russia.
Soltysova A; Kuzin A; Samarkina E; Zatkova A
Eur J Hum Genet; 2022 Feb; 30(2):237-242. PubMed ID: 34504318
[TBL] [Abstract][Full Text] [Related]
18. Amyloidosis in alkaptonuria.
Millucci L; Braconi D; Bernardini G; Lupetti P; Rovensky J; Ranganath L; Santucci A
J Inherit Metab Dis; 2015 Sep; 38(5):797-805. PubMed ID: 25868666
[TBL] [Abstract][Full Text] [Related]
19. Expression of tyrosine pathway enzymes in mice demonstrates that homogentisate 1,2-dioxygenase deficiency in the liver is responsible for homogentisic acid-derived ochronotic pigmentation.
Wilson PJM; Ranganath LR; Bou-Gharios G; Gallagher JA; Hughes JH
JIMD Rep; 2021 Mar; 58(1):52-60. PubMed ID: 33728247
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation.
Introne WJ; Phornphutkul C; Bernardini I; McLaughlin K; Fitzpatrick D; Gahl WA
Mol Genet Metab; 2002; 77(1-2):136-42. PubMed ID: 12359141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
